Article

Evaluating the Benefits of Tegafur-Uracil Adjuvant Therapy in Low-Risk Stage IIa Colon Cancer: Insights from a Decade-Long Study

2025-01-17

Abstract excerpt

<title>Abstract</title> <p> Background Surgical resection is the gold standard for treating non-metastatic colorectal cancer. The five-year overall survival (OS) for Stage IIIa patients is longer than that for Stage IIa patients, highlighting the importance of adjuvant therapy (ACT) for Stage IIa. This study aims to evaluate the treatment outcomes and prognostic factors for Stage IIa colon cancer at our hospita...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c12aaff2-1444-5254-b94c-f36e2220ef2a
DOI: 10.21203/rs.3.rs-5816207/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Evaluating the Benefits of Tegafur-Uracil Adjuvant Therapy in Low-Risk Stage IIa Colon Cancer: Insights from a Decade-Long StudyDOI 10.21203/rs.3.rs-5816207/v1Read

Evaluation of Postoperative Chemotherapy Duration of Capecitabine-Alone Regimen for Surgery Treated Elderly Colon Cancer Patients : A Cohort StudySemantic proximity Read

Factors Affecting Survival Prognosis of Patients with Rectal Cancer After Neoadjuvant ChemoradiotherapySemantic proximity Read

Redefining high-risk patients with stage II colon cancer by risk index and microRNA-21: results from a population-based cohortSemantic proximity Read

The effects of chemoradiotherapy in IIA（T3N0M0）rectosigmoid junction cancer : a population-based studySemantic proximity Read

Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision.Semantic proximity Read

Development and validation of a prognostic nomogram for patients with stage II colon mucinous adenocarcinomaSemantic proximity Read

Adjuvant chemotherapy for poor-responders to neoadjuvant therapy in locally advanced rectal cancer: does it improve the prognosis?Semantic proximity Read

Is it Possible to Predict Benefit from 5FU Adjuvant Therapy in Stage III Colon Cancer Patients?Semantic proximity Read

Short-term Efficacy Comparison of Intracorporeal versus Extracorporeal Ileocolonic Anastomosis in Right Hemicolectomy for Colon Cancer---A Single-Center, Retrospective StudySemantic proximity Read

Survival after Curative Resection for Stage I Colorectal Mucinous AdenocarcinomaSemantic proximity Read

Extensive multimodal treatments with Total Neoadjuvant Therapy followed by Total Mesorectal Excision for locally advanced rectal cancer allows fit older patients to achieve good oncologic and functional outcomes. Real world data and proof of conceptSemantic proximity Read

Assessing the practice of Total Neoadjuvant Therapy for rectal cancer: an online survey among Radiation Oncology Departments in Germany and German-Speaking Regions of Austria and SwitzerlandSemantic proximity Read